Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.

Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson RC.

Addict Biol. 2004 Mar;9(1):67-72.

PMID:
15203441
2.

Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.

Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson R, O'Neil P.

Addict Biol. 2004 Mar;9(1):59-65.

PMID:
15203440
3.

Blood naltrexone levels over time following naltrexone implant.

Ngo HT, Arnold-Reed DE, Hansson RC, Tait RJ, Hulse GK.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):23-8.

PMID:
17651881
4.

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.

Hulse GK, Morris N, Arnold-Reed D, Tait RJ.

Arch Gen Psychiatry. 2009 Oct;66(10):1108-15. doi: 10.1001/archgenpsychiatry.2009.130.

PMID:
19805701
5.

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.

Hulse GK, Ngo HT, Tait RJ.

Biol Psychiatry. 2010 Aug 1;68(3):296-302. doi: 10.1016/j.biopsych.2010.04.003.

PMID:
20537615
7.

Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H.

Br J Psychiatry. 2009 Jun;194(6):541-6. doi: 10.1192/bjp.bp.108.055319.

9.

Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.

Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC.

Alcohol Clin Exp Res. 2006 Mar;30(3):480-90.

PMID:
16499489
10.

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.

Ngo HT, Tait RJ, Hulse GK.

Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457.

PMID:
18391134
11.

Naltrexone implant and blood naltrexone levels over pregnancy.

Hulse GK, Arnold-Reed DE, O'Neil G, Hansson RC.

Aust N Z J Obstet Gynaecol. 2003 Oct;43(5):386-8. No abstract available.

PMID:
14717319
12.

Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.

Toennes SW, Kauert GF, Grüsser SM, Jäkel W, Partecke G.

J Pharm Biomed Anal. 2004 Apr 1;35(1):169-76.

PMID:
15030891
13.

Hospital morbidity associated with the natural history of heroin use.

Tait RJ, Hulse GK.

J Opioid Manag. 2008 Sep-Oct;4(5):321-7.

PMID:
19070270
14.

Mental health outcomes following naltrexone implant treatment for heroin-dependence.

Ngo HT, Tait RJ, Arnold-Reed DE, Hulse GK.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):605-12.

PMID:
17229510
15.

Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts.

Ferrari A, Bertolotti M, Dell'Utri A, Avico U, Sternieri E.

Drug Alcohol Depend. 1998 Nov 1;52(3):211-20.

PMID:
9839147
16.

Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.

Turncliff RZ, Dunbar JL, Dong Q, Silverman BL, Ehrich EW, Dilzer SC, Lasseter KC.

J Clin Pharmacol. 2005 Nov;45(11):1259-67.

PMID:
16239359
17.

Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.

Tait RJ, Ngo HT, Hulse GK.

J Subst Abuse Treat. 2008 Sep;35(2):116-24.

PMID:
17931824
18.

Using naltrexone implants in the management of the pregnant heroin user.

Hulse G, O'Neil G.

Aust N Z J Obstet Gynaecol. 2002 Nov;42(5):569-73.

PMID:
12495120
19.
20.

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

McCaul ME, Wand GS, Rohde C, Lee SM.

Alcohol Clin Exp Res. 2000 Sep;24(9):1385-91.

PMID:
11003204

Supplemental Content

Support Center